BACKGROUND: The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and ...

Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.

Ostrominski JW, Greene SJ, Patel RB, Solomon NC, Chiswell K, DeVore AD, Butler J, Heidenreich PA, Huang JC, Kittleson MM, et ...

This week please join author Kieran Docherty and Associate Editor Justin Ezekowitz as they discuss the article "Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure ...

Advances in critical care therapies for patients with cardiogenic shock (CS), including temporary mechanical circulatory support and multidisciplinary shock teams, have led to improved survival to ...

Cardiovascular disease (CVD) is the leading cause of death among women. With the recognition of disparities in cardiovascular care in women, the American Heart Association’s Go Red for Women campaign ...

The coexistence of transthyretin cardiac amyloidosis (ATTR‐CA) and aortic stenosis (AS) is increasingly recognized, but the clinical consequences are unclear. We aimed to characterize clinical ...

Prediction tools that combine information in a systematic way could be used by clinicians to improve the accuracy of prognoses and personalize rehabilitation plans. These improvements could reduce ...

Cardiovascular diseases such as stroke are a major cause of morbidity and mortality for patients with chronic kidney disease (CKD). The underlying mechanisms connecting CKD and cardiovascular disease ...

Leading coronary artery, structural heart, and vascular disease science that advances practice and improves patient outcomes ...

Because of these effects, understanding the out-of-pocket costs for SGLT-2 inhibitors is essential. However, estimates for out-of-pocket costs are limited with no nationally representative or ...